ATACCBODY Trademark

Trademark Overview


On Thursday, April 30, 2020, a trademark application was filed for ATACCBODY with the United States Patent and Trademark Office. The USPTO has given the ATACCBODY trademark a serial number of 88894753. The federal status of this trademark filing is REGISTERED as of Tuesday, June 6, 2023. This trademark is owned by Phanes Therapeutics, Inc.. The ATACCBODY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; development of pharmaceutical preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of p...
ataccbody

General Information


Serial Number88894753
Word MarkATACCBODY
Filing DateThursday, April 30, 2020
Status700 - REGISTERED
Status DateTuesday, June 6, 2023
Registration Number7075638
Registration DateTuesday, June 6, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements


Goods and ServicesResearch and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; development of pharmaceutical preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of pharmaceutical research and development; research and development in the field of medicine, the prevention, treatment and management of illness, health care delivery; medical research; medical laboratories; medical and scientific research in the field of medicine, the prevention, treatment and management of illness, health care delivery

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code042
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateThursday, March 16, 2023

Trademark Owner History


Party NamePhanes Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NamePhanes Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NamePhanes Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, June 6, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 6, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, April 29, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, April 28, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 7, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 21, 2023USE AMENDMENT FILED
Thursday, April 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 21, 2023TEAS STATEMENT OF USE RECEIVED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022SOU EXTENSION 4 GRANTED
Wednesday, October 26, 2022SOU EXTENSION 4 FILED
Wednesday, October 26, 2022TEAS EXTENSION RECEIVED
Saturday, April 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2022SOU EXTENSION 3 GRANTED
Thursday, April 21, 2022SOU EXTENSION 3 FILED
Thursday, April 21, 2022TEAS EXTENSION RECEIVED
Tuesday, July 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 9, 2021SOU EXTENSION 2 GRANTED
Friday, July 9, 2021SOU EXTENSION 2 FILED
Friday, July 9, 2021TEAS EXTENSION RECEIVED
Wednesday, March 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 1, 2021SOU EXTENSION 1 GRANTED
Monday, March 1, 2021SOU EXTENSION 1 FILED
Monday, March 1, 2021TEAS EXTENSION RECEIVED
Tuesday, February 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 23, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 27, 2020ASSIGNED TO EXAMINER
Tuesday, May 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 4, 2020NEW APPLICATION ENTERED